A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
Clinical trial NCT02975934 · COMPLETED
Trial details
- NCT number
- NCT02975934
- Sponsor
- pharmaand GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-13
- Primary completion
- 2022-08-25
- Enrollment
- 405
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.